A day after engineering giant Siemens appealed to French lawmakers that its acquisition of Alstom would be more beneficial than General Electric’s proposed purchase, German’s competition regulator is warning that Siemens would face strict regulatory review of the deal by the European Commission.
Germany’s Federal Cartel Office head Andreas Mundt spoke …read more
Swiss food conglomerate Nestle is reportedly expanding its skincare portfolio after acquiring various injectable treatment patents in a $1.4 billion deal.
Reports say Nestle acquired the rights for various wrinkle treatments from Valeant Pharmaceuticals.
While the deal allows Nestle to own the rights to treatments acquired when it fully took over its …read more
Once at the top of its game, advisor Nomura Holdings is now facing one of its biggest slumps as the merger deal that was supposed to be its largest of the year suddenly imploded.
According to reports, Nomura, Japan’s largest securities firm, is set to have its fourth straight year below …read more
Valeant Pharmaceuticals has reportedly upped its unsolicited offer to acquire the maker of Botox.
Reports say Valeant increased its bid to $49.4 billion to acquire Canada-based Allergan in hopes of swaying approval from the firm and its shareholders. The original acquisition offer was first introduced last month.